Asthma Treatment Aerospan Has Been Discontinued
Aerospan, an orally inhaled corticosteroid, is indicated for the maintenance treatment of asthma as prophylactic therapy in adults and pediatric patients 6 years of age and older. The Company stated the discontinuation was a business decision and not related to the product's quality, safety or efficacy.
Both the 60- and 120-actuation sizes have been discontinued.
For more information call (800) RX-MYLAN or visit FDA.gov.